α-Bisabolol inhibits invasiveness and motility in pancreatic cancer through KISS1R

Anticancer Research

Volumn 36, Issue 2, 2016, Pages 583-590

  Uno, Masanori ^a   Kokuryo, Toshio ^a   Yokoyama, Yukihiro ^a   Senga, Takeshi ^b   Nagino, Masato ^a  

^a Graduate School of Medicine   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

KISS1R; KISS1R siRNA; Metastasis suppressor gene; Pancreatic cancer; Bisabolol

Indexed keywords

ANTINEOPLASTIC AGENT; BISABOLOL; EARLY GROWTH RESPONSE FACTOR 1; KISSPEPTIN; KISSPEPTIN 1 RECEPTOR; UNCLASSIFIED DRUG; EGR1 PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR; KISS1R PROTEIN, HUMAN; MESSENGER RNA; SESQUITERPENE; SMALL INTERFERING RNA;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR INVASION; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PANCREATIC NEOPLASMS; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SESQUITERPENES; TUMOR CELLS, CULTURED;

EID: 84962176140     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61(2): 69-90, 2011.
2. Ducreux M, Boige V, Goere D, Deutsch E, Ezra P, Elias D and Malka D: The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: From pathogenesis to cure. Best Pract Res Clin Gastroenterol 21(6): 997-1014, 2007.
3. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH and Lillemoe KD: Resected adenocarcinoma of the pancreas-616 patients: Results, outcomes, and prognostic indicators. J Gastrointest Surg 4(6): 567-579, 2000.
4. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, Hodgin MB, Sauter PK, Hruban RH, Riall TS, Schulick RD, Choti MA, Lillemoe KD and Yeo CJ: 1423 pancreaticoduodenectomies for pancreatic cancer: A singleinstitution experience. J Gastrointest Surg 10(9): 1199-1210; discussion 1210-1191, 2006.
5. Oberstein PE and Olive KP: Pancreatic cancer: Why is it so hard to treat? Therap Adv Gastroenterol 6(4): 321-337, 2013.
6. Cavalieri E, Rigo A, Bonifacio M, Carcereri de Prati A, Guardalben E, Bergamini C, Fato R, Pizzolo G, Suzuki H and Vinante F: Pro-apoptotic activity of alpha-bisabolol in preclinical models of primary human acute leukemia cells. J Transl Med 9: 45, 2011.
7. Cavalieri E, Mariotto S, Fabrizi C, de Prati AC, Gottardo R, Leone S, Berra LV, Lauro GM, Ciampa AR and Suzuki H: Alphabisabolol, a nontoxic natural compound, strongly induces apoptosis in glioma cells. Biochem Biophys Res Commun 315(3): 589-594, 2004.
8. Chen W, Hou J, Yin Y, Jang J, Zheng Z, Fan H and Zou G: Alphabisabolol induces dose- And time-dependent apoptosis in HEPG2 cells via a FAS- And mitochondrial-related pathway, involves p53 and NFkappaB. Biochem Pharmacol 80(2): 247-254, 2010.
9. Seki T, Kokuryo T, Yokoyama Y, Suzuki H, Itatsu K, Nakagawa A, Mizutani T, Miyake T, Uno M, Yamauchi K and Nagino M: Antitumor effects of alpha-bisabolol against pancreatic cancer. Cancer Sci 102(12): 2199-2205, 2011.
10. Cen P, Ni X, Yang J, Graham DY and Li M: Circulating tumor cells in the diagnosis and management of pancreatic cancer. Biochim Biophys Acta 1826(2): 350-356, 2012.
11. Abdel-Malak NA, Mofarrahi M, Mayaki D, Khachigian LM and Hussain SN: Early growth response-1 regulates angiopoietin-1- induced endothelial cell proliferation, migration, and differentiation. Arterioscler Thromb Vasc Biol 29(2): 209-216, 2009.
12. Lucerna M, Pomyje J, Mechtcheriakova D, Kadl A, Gruber F, Bilban M, Sobanov Y, Schabbauer G, Breuss J, Wagner O, Bischoff M, Clauss M, Binder BR and Hofer E: Sustained expression of early growth response protein-1 blocks angiogenesis and tumor growth. Cancer Res 66(13): 6708-6713, 2006.
13. Lee KH and Kim JR: Hepatocyte growth factor induced upregulations of VEGF through EGR-1 in hepatocellular carcinoma cells. Clin Exp Metastasis 26(7): 685-692, 2009.
14. Beck BH and Welch DR: The kiss1 metastasis suppressor: A good night kiss for disseminated cancer cells. Eur J Cancer 46(7): 1283-1289, 2010.
15. Cho SG, Li D, Tan K, Siwko SK and Liu M: KISS1 and its Gprotein- coupled receptor GPR54 in cancer development and metastasis. Cancer Metastasis Rev 31(3-4): 585-591, 2012.
16. Masui T, Doi R, Mori T, Toyoda E, Koizumi M, Kami K, Ito D, Peiper SC, Broach JR, Oishi S, Niida A, Fujii N and Imamura M: Metastin and its variant forms suppress migration of pancreatic cancer cells. Biochem Biophys Res Commun 315(1): 85-92, 2004.
17. Nagai K, Doi R, Katagiri F, Ito T, Kida A, Koizumi M, Masui T, Kawaguchi Y, Tomita K, Oishi S, Fujii N and Uemoto S: Prognostic value of metastin expression in human pancreatic cancer. J Exp Clin Cancer Res 28: 9, 2009.